Sign In
Buy NNBR
NN Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | -$0.0500 |
| EPS actual | $0.0200 |
| EPS Surprise | 140.00% |
| Revenue estimate | 106.587M |
| Revenue actual | 118.452M |
| Revenue Surprise | 11.13% |
| Release date | Mar 04, 2026 |
| EPS estimate | $0.0200 |
| EPS actual | -$0.360 |
| EPS Surprise | -1,900.00% |
| Revenue estimate | 105.364M |
| Revenue actual | 104.715M |
| Revenue Surprise | -0.615% |
| Release date | Oct 29, 2025 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.0100 |
| Revenue estimate | 105.364M |
| Revenue actual | 103.882M |
| Revenue Surprise | -1.41% |
| Release date | Aug 06, 2025 |
| EPS estimate | -$0.0100 |
| EPS actual | $0.0200 |
| EPS Surprise | 300.00% |
| Revenue estimate | 110.794M |
| Revenue actual | 107.921M |
| Revenue Surprise | -2.59% |
Last 4 Quarters for NN
Below you can see how NNBR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $2.14 |
| EPS estimate | -$0.0100 |
| EPS actual | $0.0200 |
| EPS surprise | 300.00% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $1.95 |
| Aug 01, 2025 | $2.00 |
| Aug 04, 2025 | $2.18 |
| Aug 05, 2025 | $2.14 |
| Aug 06, 2025 | $2.14 |
| Aug 07, 2025 | $2.20 |
| Aug 08, 2025 | $2.12 |
| Aug 11, 2025 | $2.16 |
| Aug 12, 2025 | $2.40 |
| 4 days before | 9.74% |
| 4 days after | 12.15% |
| On release day | 2.80% |
| Change in period | 23.08% |
| Release date | Oct 29, 2025 |
| Price on release | $1.90 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.0100 |
| Date | Price |
|---|---|
| Oct 23, 2025 | $1.79 |
| Oct 24, 2025 | $1.82 |
| Oct 27, 2025 | $1.92 |
| Oct 28, 2025 | $1.88 |
| Oct 29, 2025 | $1.90 |
| Oct 30, 2025 | $1.63 |
| Oct 31, 2025 | $1.71 |
| Nov 03, 2025 | $1.85 |
| Nov 04, 2025 | $1.80 |
| 4 days before | 6.15% |
| 4 days after | -5.26% |
| On release day | -14.21% |
| Change in period | 0.559% |
| Release date | Mar 04, 2026 |
| Price on release | $1.53 |
| EPS estimate | $0.0200 |
| EPS actual | -$0.360 |
| EPS surprise | -1,900.00% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $1.50 |
| Feb 27, 2026 | $1.51 |
| Mar 02, 2026 | $1.48 |
| Mar 03, 2026 | $1.49 |
| Mar 04, 2026 | $1.53 |
| Mar 05, 2026 | $1.45 |
| Mar 06, 2026 | $1.36 |
| Mar 09, 2026 | $1.28 |
| Mar 10, 2026 | $1.30 |
| 4 days before | 2.00% |
| 4 days after | -15.03% |
| On release day | -5.23% |
| Change in period | -13.33% |
| Release date | May 06, 2026 |
| Price on release | $2.52 |
| EPS estimate | -$0.0500 |
| EPS actual | $0.0200 |
| EPS surprise | 140.00% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $2.32 |
| May 01, 2026 | $2.46 |
| May 04, 2026 | $2.45 |
| May 05, 2026 | $2.47 |
| May 06, 2026 | $2.52 |
| May 07, 2026 | $2.76 |
| May 08, 2026 | $2.80 |
| May 11, 2026 | $2.58 |
| May 12, 2026 | $2.37 |
| 4 days before | 8.62% |
| 4 days after | -5.95% |
| On release day | 9.52% |
| Change in period | 2.16% |
NN Earnings Call Transcript Summary of Q1 2026
NN, Inc. reported a strong Q1 2026 driven by favorable sales mix (notably electric grid, data center, defense electronics and select medical programs), improved operating efficiencies and cost-out actions. Net sales were $118.5M (up ~12% YoY) and adjusted EBITDA rose to $14.1M (11.9% margin), delivering the highest trailing 12-month adjusted EBITDA in five years. Management raised full‑year 2026 guidance, citing broad-based wins (up with 22 of top 30 customers), expanding data center content (including liquid cooling connectors) and ongoing portfolio diversification away from legacy automotive exposure. Key strategic priorities are scaling data center and electric grid to a near‑term $100M target, expanding defense electronics and growing medical (which is behind plan but now profitable), while maintaining disciplined automotive exposure. Management also pulled forward long‑term targets from 2030 to 2029 (same targets: ~$600M revenue, ~13% adjusted EBITDA margin) given the faster-than-expected progress. Liquidity has improved (CARES Act proceeds received) and the company continues to evaluate strategic financing alternatives.
